Hemophilia Pipeline Drugs Assessment

Posted by ahila on April 3rd, 2018

Hemophilia Pipeline Drugs Assessment: Clinical Trails Analysis, Player Profiles, Collaborations, Key Targets, Geographic Focus, and Data Publications, 2018

Hemophilia Pipeline Drugs Assessment


Hemophilia is a rare blood disorder, in which blood doesn’t clot normally due to lack of sufficient clotting factors. Hemophilia A and B both are inherited diseases. Hemophilia A, B caused due to deficiency of clotting factor VIII,IX respectively. Hemophilia causes by genetic mutation. The mutations that involve genes that code the clotting factors.

Hereditary hemophilia can be easily diagnosed during the pregnancy if the fetus is suffering from hemophilia. In absence of hereditary hemophilia, disease may be due to the spontaneous mutations in gene. Hemophilia in both children and adults, blood test to determine the clotting factor may be preferred. Treatment depends on the type of hemophilia.

A sample of this report is available upon request @



Like it? Share it!


About the Author

Joined: March 20th, 2018
Articles Posted: 168

More by this author